DEZAWA GOLDEN IV Trademark
Trademark Overview
On Tuesday, March 24, 2026, a trademark application was filed for DEZAWA GOLDEN IV with the United States Patent and Trademark Office. The USPTO has given the DEZAWA GOLDEN IV trademark a serial number of 99721392. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 24, 2026. This trademark is owned by MUSECELL INNOVATIONS PTE. LTD.. The DEZAWA GOLDEN IV trademark is filed in the Pharmaceutical Products category with the following description:
Cells for medical purposes; Cells for medical use; Cellular function activating agents for medical purposes; Cellulose esters for pharmaceutical purposes; Cellulose ethers for pharmaceutical purposes; Cellulose for pharmaceutical purposes; Chemicals for cell separation and cultivation for medical or veterinary purposes; Chemicals for separating and cultivating cells for medical or veterinary purposes; Living cells for medical purposes; Living cells for medical use; Pharmaceutical compositions containing stem cells for the treatment of diseases; Pharmaceutical preparations containing stem cells; Pharmaceutical preparations for activating cellular function; Stem cells for medical purposes; Autoinjectors prefilled with pharmaceutical preparations; Immunological products for intravenous injections; Injectable medicinal solutions; Injectable solutions for medical purposes; Injectable solutions for use in inhibiting peristalsis for medical purposes; Pharmaceutical preparations sold in prefil...
General Information
| Serial Number | 99721392 |
| Word Mark | DEZAWA GOLDEN IV |
| Filing Date | Tuesday, March 24, 2026 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Tuesday, March 24, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Cells for medical purposes; Cells for medical use; Cellular function activating agents for medical purposes; Cellulose esters for pharmaceutical purposes; Cellulose ethers for pharmaceutical purposes; Cellulose for pharmaceutical purposes; Chemicals for cell separation and cultivation for medical or veterinary purposes; Chemicals for separating and cultivating cells for medical or veterinary purposes; Living cells for medical purposes; Living cells for medical use; Pharmaceutical compositions containing stem cells for the treatment of diseases; Pharmaceutical preparations containing stem cells; Pharmaceutical preparations for activating cellular function; Stem cells for medical purposes; Autoinjectors prefilled with pharmaceutical preparations; Immunological products for intravenous injections; Injectable medicinal solutions; Injectable solutions for medical purposes; Injectable solutions for use in inhibiting peristalsis for medical purposes; Pharmaceutical preparations sold in prefilled injectors; Intravenous fluids used for the delivery of pharmaceutical preparations; Intravenous solutions for medical purposes; Immunosuppressive pharmaceutical preparations; Pharmaceutical preparations for the treatment of cystic fibrosis; Glycerophosphates; Phosphates for pharmaceutical purposes; Cardiovascular agents for medical purposes; Cardiovascular pharmaceutical preparations; Cardiovascular pharmaceuticals; Cardiovascular preparations; Cardiovascular treatment preparations; Drugs for the treatment of cardiovascular diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations and substances for the prevention of cardiovascular diseases and disorders; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; Pharmaceutical preparations for the prevention of cardiovascular disorders; Pharmaceutical preparations for the treatment of cardiovascular disease; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations for treating cardiovascular diseases; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Anti-ulcer agents; Pharmaceutical preparations being antiulceratives; Pharmaceutical preparations for the treatment of chronic liver diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 24, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | MUSECELL INNOVATIONS PTE. LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | Singapore 049319
SG |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 24, 2026 | NEW APPLICATION ENTERED |
| Tuesday, March 24, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 24, 2026 | APPLICATION FILING RECEIPT MAILED |
